Publication:
Oleic Acid Protects Against Insulin Resistance by Regulating the Genes Related to the PI3K Signaling Pathway

dc.contributor.authorLópez-Gómez, Carlos
dc.contributor.authorSantiago-Fernández, Concepción
dc.contributor.authorGarcía-Serrano, Sara
dc.contributor.authorGarcía-Escobar, Eva
dc.contributor.authorGutiérrez-Repiso, Carolina
dc.contributor.authorRodríguez-Díaz, Cristina
dc.contributor.authorHo-Plágaro, Ailec
dc.contributor.authorMartín-Reyes, Flores
dc.contributor.authorGarrido-Sánchez, Lourdes
dc.contributor.authorValdés, Sergio
dc.contributor.authorRodríguez-Cañete, Alberto
dc.contributor.authorRodríguez-Pacheco, Francisca
dc.contributor.authorGarcía-Fuentes, Eduardo
dc.contributor.authoraffiliation[López-Gómez,C; Santiago-Fernández,C; Rodríguez-Díaz,C; Ho-Plágaro,A; Martín-Reyes,F; Rodríguez-Pacheco,F; García-Fuentes,E] Unidad de Gestión Clínica de Aparato Digestivo, Hospital Universitario Virgen de la Victoria/Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [García-Serrano,S; García-Escobar,E; Valdés,S] Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario de Málaga/Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [García-Serrano,S; García-Escobar,E; Valdés,S; Rodríguez-Pacheco,F] CIBER de Diabetes y Enfermedades Metabólicas Asociadas-CIBERDEM, Málaga, Spain. [Gutiérrez-Repiso,C; Garrido-Sánchez,L] Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria/Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [Garrido-Sánchez,L] CIBER Fisiopatología de la Obesidad y Nutrición-CIBEROBN, Málaga, Spain. [Rodríguez-Cañete,A] Unidad de Gestión Clínica de Cirugía General, Digestiva y Trasplantes, Hospital Regional Universitario de Málaga, Málaga, Spain.
dc.date.accessioned2024-02-12T19:46:58Z
dc.date.available2024-02-12T19:46:58Z
dc.date.issued2020-08-12
dc.description.abstractThe effects of different types of fatty acids on the gene expression of key players in the IRS1/PI3K signaling pathway have been poorly studied. Material and Methods: We analyzed IRS1, p85α, and p110β mRNA expression and the fatty acid composition of phospholipids in visceral adipose tissue from patients with morbid obesity and from non-obese patients. Moreover, we analyzed the expression of those genes in visceral adipocytes incubated with oleic, linoleic, palmitic and dosahexaenoic acids. Results: We found a reduced IRS1 expression in patients with morbid obesity, independent of insulin resistance, and a reduced p110β expression in those with lower insulin resistance. A positive correlation was found between p85α and stearic acid, and between IRS1 and p110β with palmitic and dosahexaenoic acid. In contrast, a negative correlation was found between p85α and oleic acid, and between IRS1 and p110β with linoleic, arachidonic and adrenic acid. Incubation with palmitic acid decreased IRS1 expression. p85α was down-regulated after incubation with oleic and dosahexaenoic acid and up-regulated with palmitic acid. p110β expression was increased and decreased after incubation with oleic and palmitic acid, respectively. The ratio p85α/p110β was decreased by oleic and dosahexaenoic acid and increased by palmitic acid. Conclusions: Our in vitro results suggest a detrimental role of palmitic acid on the expression of gene related to insulin signaling pathway, with oleic acid being the one with the higher and more beneficial effects. DHA had a slight beneficial effect. Fatty acid-induced regulation of genes related to the IRS1/PI3K pathway may be a novel mechanism by which fatty acids regulate insulin sensitivity in visceral adipocytes.
dc.description.sponsorshipThis work was supported in part by a grant from the Instituto de Salud Carlos III, Spain (PI09/01016), and from a grant of the Consejería de Economía, Innovación y Ciencia de la Junta de Andalucía, Spain (CTS8081). This study has been co-funded by FEDER funds (“A way to make Europe”) (“Andalucía se mueve con Europa”). CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) are ISCIII projects. all authors have read the journal’s authorship statement. CLG is supported by a grant from the Ministerio de Educación y Formación Professional (Spain) (IJCI-2017-31466). CSF is supported by a grant from the ISCIII (Spain) (FI16/00241). CGR is supported by a grant from the Ministerio de Educación y Formación Professional (Spain) (IJCI-2017-33065). CRD is supported by a grant from the ISCIII (Spain) (CD18/00188). AHP is supported by a grant from the Ministerio de Educación y Formación Professional (Spain) (FPU14/01972). FMR is supported by a grant from the ISCIII (Spain) (“PFIS” program, FI19/00189). LGS is supported by the Miguel Servet program from the ISCIII (Spain) (“Miguel Servet II” program, CPII18/00030) and Nicolas Monardes program from the Consejería de Salud de Andalucía (Spain) (C-0028-2018). FRP is supported by the Miguel Servet program from the ISCIII (Spain) (“Miguel Servet I” program, CP18/00042). EGF is supported by the Nicolas Monardes program from the Consejería de Salud de Andalucía (Spain) (C-0031-2016).
dc.identifier.doi10.3390/jcm9082615
dc.identifier.e-issn2077-0383es_ES
dc.identifier.journalJournal of Clinical Medicinees_ES
dc.identifier.otherhttp://hdl.handle.net/10668/4103
dc.identifier.pubmedID32806641es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18095
dc.language.isoeng
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.publisherversionhttps://www.mdpi.com/2077-0383/9/8/2615/htmes
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMorbid obesity
dc.subjectInsulin resistance
dc.subjectIRS1
dc.subjectp85α
dc.subjectp110β
dc.subjectPalmitic acid
dc.subjectOleic acid
dc.subjectDocosahexaenoic acid
dc.subjectLinoleic acid
dc.subjectVisceral adipose tissue
dc.subjectObesidad mórbida
dc.subjectResistencia a la insulina
dc.subjectÁcido palmítico
dc.subjectÁcido oléico
dc.subjectÁcidos docosahexaenoicos
dc.subjectÁcido linoleico
dc.subjectGrasa intraabdominal
dc.subjectAndalucía
dc.subject.meshHumans
dc.subject.meshInsulin Resistance
dc.subject.meshPhosphatidylinositol 3-Kinases
dc.subject.meshIntra-Abdominal Fat
dc.subject.meshObesity, Morbid
dc.subject.meshAdipocytes
dc.subject.meshSignal Transduction
dc.subject.meshGene Expression
dc.subject.meshPalmitic Acids
dc.subject.meshPhospholipids
dc.subject.meshStearic Acids
dc.subject.meshOleic Acids
dc.subject.meshInsulins
dc.subject.meshRNA, Messenger
dc.subject.meshFatty Acids, Unsaturated
dc.subject.meshSpain
dc.titleOleic Acid Protects Against Insulin Resistance by Regulating the Genes Related to the PI3K Signaling Pathway
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication30293a55-0e53-431f-ae8c-14ab01127be9
relation.isPublisherOfPublication.latestForDiscovery30293a55-0e53-431f-ae8c-14ab01127be9

Files